Sumitomo Mitsui Trust Holdings, Inc. Novo Nordisk A S Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 4,339 shares of NVO stock, worth $553,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,339
Previous 9,226
52.97%
Holding current value
$553,352
Previous $1.18 Million
47.72%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,991Shares Held
318MCall Options Held
5.23MPut Options Held
4.97M-
Jennison Associates LLC21.2MShares$2.71 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.86 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.81 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.71 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.6 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $288B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...